Sunstein Insights
Back to All Publications
What Kind of Patent Portfolios Will Matter to Life Science Companies in the Next Five Years
"What Kind of Patent Portfolios Will Matter to Life Science Companies in the Next Five Years" has just been published by Financier Worldwide. See the lead article in 2010 Biotech and Life Sciences Sector.
Most Popular
-
Massachusetts Jury Sets New Record Under Federal Defend Trade Secrets Act With $452 Million Damages Award
-
New Trademark Office Fees Increase Cost, Headaches
-
The New York Times v. OpenAI: The Biggest IP Case Ever
-
Advertisers Beware: Falsely Advertising Products as “Patented” and “Proprietary” Can Violate the Lanham Act, Says the Federal Circuit
-
Corporate Transparency Act: To File or Not to File?
-
Wavy Baby Waves Goodbye to its Attempt at Humor
Authors
-
Steven A. Abreu
-
Robert M. Asher
-
Thomas C. Carey
-
Lawrence M. Green
-
Shane Hunter
-
Peter J. Karol
-
Kelly Kutsor
-
Christopher Lacenere, Ph.D.
-
Michele Liu Baillie
-
Sunstein
-
London K. Lundstrum
-
Ian Mahany-Horton
-
Kevin R. Mosier
-
John W. Powell
-
Rob D. Pyatt
-
Jackie Salwa
-
Katherine W. Soule
-
Sharona H. Sternberg
-
Bruce D. Sunstein
-
Kerry L. Timbers
-
Lisa M. Tittemore
We use cookies to improve your site experience, distinguish you from other users and support the marketing of our services. These cookies may store your personal information. By continuing to use our website, you agree to the storing of cookies on your device. For more information, please visit our Privacy Notice.